Eton Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotens…

Biotechnology
US, Deer Park [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Eton Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ETON's Analysis
CIK: 1710340 CUSIP: 29772L108 ISIN: US29772L1089 LEI: - UEI: -
Secondary Listings
ETON has no secondary listings inside our databases.